APA (7th ed.) Citation

EM, J., N, W., V, d. W., CM, B., K, R., MN, V., . . . SM, W. (2025). Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: Circulating tumor DNA analysis of a randomized phase 3 trial. Nature medicine, 31(11), 3662. https://doi.org/10.1038/s41591-025-03935-w

Chicago Style (17th ed.) Citation

EM, Jongbloed, et al. "Early Versus Deferred Use of CDK4/6 Inhibitors in Advanced Breast Cancer: Circulating Tumor DNA Analysis of a Randomized Phase 3 Trial." Nature Medicine 31, no. 11 (2025): 3662. https://doi.org/10.1038/s41591-025-03935-w.

MLA (9th ed.) Citation

EM, Jongbloed, et al. "Early Versus Deferred Use of CDK4/6 Inhibitors in Advanced Breast Cancer: Circulating Tumor DNA Analysis of a Randomized Phase 3 Trial." Nature Medicine, vol. 31, no. 11, 2025, p. 3662, https://doi.org/10.1038/s41591-025-03935-w.